Allergan Plc (AGN)

193.02  +0.03 (+0.02%)

After market: 193.7 +0.68 (+0.35%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Allergan Plc

NYSE:AGN (5/8/2020, 7:04:06 PM)

After market: 193.7 +0.68 (+0.35%)

193.02

+0.03 (+0.02%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap63.50B
Shares
PE10.94
Fwd PE11.56
Dividend Yield1.53%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

AGN Daily chart

Company Profile

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.

Company Info

Allergan Plc

CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK

DUBLIN L2 D17 E400

P: 862-261-7000

CEO: Brenton L. Saunders

AGN News

News Image8 days ago - Get NewsDr. Anureet Bajaj Co-Chairs LIMITLESS Leaders Summit to Encourage Advancement of Early-Career Women Surgeons
News Image2 months ago - Seeking AlphaAbbVie cites tailwinds to Botox sales from weight loss drugs

AbbVie's (ABBV) wrinkle therapy Botox-led aesthetics franchise may benefit from the increasing demand for obesity drugs in the long-term. Find out the reasons.

News Image3 months ago - Seeking AlphaAbbVie sees maintaining Botox position in aesthetics: report (NYSE:ABBV)

Despite increasing competition, AbbVie reportedly expects Botox to maintain its leading market share position in the aesthetics market. Read more here.

News Image5 months ago - Seeking AlphaBioMarin could be very 'digestible' to larger cap peers in US/Europe - analyst

BioMarin's shares surge 12% after activist investor Elliott Management takes $1 billion stake; potential takeover target for larger cap peer.

News Image5 months ago - Seeking AlphaAbbVie Allergan reports positive Phase 3 data for new wrinkle treatment (NYSE:ABBV)

AbbVie (ABBV) Allergan Aesthetics reports positive Phase 3 results for its new wrinkle therapy, BoNT/E, for the treatment of glabellar lines between eyebrows. Read more here.

News Image6 months ago - SBWireA Comprehensive Study Exploring Obesity Treatment Market : Key Players Orexigen Therapeutics, Cousin Biotech, EnteroMedics

Get an extensive Obesity Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.

AGN Twits

Here you can normally see the latest stock twits on AGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example